[Progress in autism: de novo mutation and CHD8 functions]

Area of Science:

• Neurodevelopmental disorders
• Genetics
• Molecular biology

Background:

• Autism spectrum disorder (ASD) is a common neurodevelopmental disorder in children.
• Currently, no effective pharmacological treatments exist for ASD.
• Recent advances include identifying de novo gene mutations associated with ASD.

Purpose of the Study:

• To highlight the significance of de novo gene mutations in autism research.
• To identify key candidate genes implicated in ASD pathogenesis.
• To explore potential molecular targets for autism diagnosis and treatment.

Main Methods:

• Whole exome sequencing was employed to identify de novo mutations in individuals with autism.
• Analysis focused on identifying frequently mutated genes in the autism cohort.

Main Results:

• The chromodomain helicase DNA-binding protein 8 (CHD8) gene was identified as the most frequently mutated gene in autism.
• CHD8 plays a role in regulating gene expression through interactions with proteins like p53 and beta-catenin.

Conclusions:

• CHD8 is a significant candidate gene for autism spectrum disorder.
• The identification of autism-candidate genes like CHD8 provides novel molecular targets.
• These targets hold promise for future diagnostic and therapeutic strategies in autism.